People that are receiving cyclosporine, tacrolimus or other agents to prevent graft-compared to-host disorder post bone marrow transplant are usually not qualified for this trial Many pharmacological inhibitors with the mtCU are divalent/trivalent cations or polycations. Divalents/trivalents can either traverse mtCU and act as aggressive inhibitors of Ca2+ like Sr2+ https://stephenfkpvy.csublogs.com/32638599/new-step-by-step-map-for-elimusertib